It has been demonstrated that PTEN could suppress proteasome activity through FOXO1-mediated transcriptional repression of proteasome subunits in both cholangiocarcinoma and gallbladder cancer [297, 298]. This evidence concerns the gene PTEN and cholangiocarcinoma.